Compound comparison
A structured research comparison between SS-31 and Thymosin Alpha 1 across compound identity, research category, evidence maturity, and interpretation boundaries.
Mitochondria-targeted tetrapeptide
Investigated in mitochondrial membrane, cardiolipin, redox, and organ-specific mitochondrial dysfunction models.
Developing clinical evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
Thymic immune-signaling peptide
Investigated in innate and adaptive immune signaling across preclinical and clinical contexts.
Substantial clinical evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
| Dimension | SS-31 | Thymosin Alpha 1 |
|---|---|---|
| Catalog identity | SS-31 is mapped to mitochondria-targeted peptide research. | Thymosin Alpha 1 is mapped to thymic immune-signaling peptide research. |
| Research category | SS-31 is primarily organized around mitochondrial dysfunction and cardiolipin-context research. | Thymosin Alpha 1 is primarily organized around immune modulation and clinical-translational literature. |
| Interpretive boundary | Use the SS-31 profile and verified study pages before inferring mechanism or outcomes. | Use the Thymosin Alpha 1 profile and verified study pages before inferring mechanism or outcomes. |
Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.
SS-31 and elamipretide literature index
PubMed, U.S. National Library of Medicine · Database
Thymosin alpha 1 literature index
PubMed, U.S. National Library of Medicine · Database
Atlas internal research database
Internal Research Database · 2026 · Database
Continue the research map